Back to BlackRock, Inc. BlackRock, Inc.

ALGSALGS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ALIGOS THERAPEUTICS INC

BlackRock, Inc. holds 30,292 shares of ALGS (ALIGOS THERAPEUTICS INC), worth $174,785 as of 2026-Q2. The position was increased (+132.3% shares).

Current Value

$174,785

Current Shares

30,292

Total Value Change

-$371,860

Total Shares Change

+16,571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
30,292
+132.3%
$174,7850.0%$5.77
25
2026-Q1
Unchanged
13,040
0.0%
$96,8870.0%$6.85
0
2025-Q4
Unchanged
13,040
0.0%
$121,5330.0%$9.12
0
2025-Q3
Unchanged
13,040
0.0%
$127,7920.0%$9.62
0
2025-Q2
Unchanged
13,040
0.0%
$94,0180.0%$7.21
0
2025-Q1
Decreased
13,040
-5.0%
$107,5800.0%$9.12
0
2024-Q4
New
13,721
-
$546,6450.0%$40.47
37

Other major holders of ALGS: ADAGE CAPITAL PARTNERS GP, L.L.C., Woodline Partners LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used